EpiPen, the life-saving allergy product, is now a $1 billion a year business for Mylan, a drug company that s currently enduring a wave of bad publicity over the extraordinary surge in EpiPen pricing.

In 2007, an EpiPen cost about $57.

I ve never used an EpiPen, but as someone with a peanut allergy who once made his own trip to the ER after a particularly unfortunate restaurant experience these Chinese beans sure are crunchy...

From FDA policy changes that expanded the number of consumers to which the product could be marketed, to legislation signed in 2013 that put EpiPens in schools across the country, the federal government has helped Mylan stack the deck for its product.

And parents who now see EpiPens as a necessity are fearing for their children s lives when they can t access the drug.

This outrageous increase in the price of EpiPens is occurring at the same time that Mylan Pharmaceutical is exploiting a monopoly market advantage that has fallen into its lap, Senator Amy Klobuchar from Minnesota said in a recent statement criticizing Mylan s business practices.

The text above is a summary, you can read full article here.